• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

20.59 +0.26 (+1.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Limited - American Depositary Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday ↗
March 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
March 02, 2023
Gainers Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million... 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2023 ↗
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
News headline image
Zai Lab's Earnings: A Preview ↗
February 28, 2023
 
Via Benzinga
News headline image
What's Going On With Zai Lab Stock ↗
January 04, 2023
Zai Lab Ltd - ADR (NASDAQ: ZLAB) shares are trading higher by 7.04% to $33.01 Wednesday morning. 
Via Benzinga
News headline image
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
March 01, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Announces Participation in March Investor Conferences
February 28, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress
February 22, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
3 More Mid-Cap Biotechs The Street Sees Doubling
February 22, 2023
According to Wall Street research groups, these three mid-cap biotechs have 2x potential. It’s for the investor to decide if the upside justifies the risk. 
Via MarketBeat
News headline image
Zai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA
February 22, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Mixed Signals On Valentine's Day: How Stocks Are Reacting To January Inflation Data ↗
February 14, 2023
Inflation cooled slightly in January, but saw increases in some areas due to the impact of surging food, energy and shelter prices on consumers, the U.S Labor Department said Tuesday.  
Via Benzinga
News headline image
Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023
February 09, 2023
Company to Host Conference Call and Webcast on March 2, 2023, at 8:00 a.m. ET 
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Announces Participation in February Investor Conferences
January 31, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by China’s NMPA
January 30, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in China’s National Reimbursement Drug List
January 18, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Appoints Michel Vounatsos To Its Board of Directors
January 09, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Stock Market Mostly Higher Amid Jobs Report; Tesla Price Cuts, GE Spinoff In Focus: Weekly Review ↗
January 06, 2023
The major indexes rallied Friday on the jobs report and services data. 
Via Investor's Business Daily
News headline image
Why Shares of Zai Lab Soared This Week ↗
January 05, 2023
A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company. 
Via The Motley Fool
News headline image
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
January 05, 2023
 
Via Benzinga
News headline image
Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients ↗
January 05, 2023
 
Via Benzinga
News headline image
This Good News on Cancer Sent 2 Nasdaq Stocks Soaring ↗
January 05, 2023
Biotech investors are optimistic about the prospects for a potential treatment. 
Via The Motley Fool
News headline image
US Stocks Open Lower; Dow Tumbles 300 Points ↗
January 05, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
January 05, 2023
 
Via Benzinga
News headline image
Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
January 05, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development
January 03, 2023
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Announces Participation in January Investor Conferences
December 20, 2022
From Zai Lab Limited
Via GlobeNewswire
News headline image
Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Phase 3 Study at the ESMO Virtual Plenary
December 15, 2022
From Zai Lab Limited
Via GlobeNewswire
News headline image
Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket ↗
December 09, 2022
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients... 
Via Benzinga
News headline image
Broadcom, DocuSign And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
December 09, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap